TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
| Image |  |
|---|---|
| Description | scientific article published on 12 March 2019 |
| Author/s |
author: Beverly Moy Julie Nangia Shannon L Puhalla Kimberly L Blackwell Robyn Burns Catherine H Van Poznak Kathryn P Componeschi Kelly Silvestri Rachel A Freedman Carey K Anders Ian E Krop Michelle E Melisko Nancy U Lin Eric Winer |
| Publication date | March 12, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |